The disclosure relates tocompositions and methods for rAAV-mediated deliveryof a transgene to a subject. In someembodiments, the rAAV transduces the prostate tissue ofa subject. In some embodiments, the methods areuseful for treatment of prostate disease (e.g.,prostatitis, BPH, prostate cancer).